GALNT1 catalyzes glycosylation of target proteins, and aberrant glycosylation of i.e. the GABAA receptor is a pathological hallmark in postmortem brains of patients suffering from schizophrenia [47]. The gene discussed is GALNT1; the disease is schizophrenia.